Faculty of Medicine Cairo University
Cairo, Al-Manial Cairo, 11956, Egypt
NCT Number: NCT07339020
Study Title:
Comparing Surgical Glue (Cyanoacrylate) vs. Omentum Tissue to Strengthen Staple Lines in Weight-Loss Sleeve Surgery
What is the purpose of this study? This study will compare two ways to strengthen the staple line during weight-loss sleeve surgery. One way uses a medical glue called cyanoacrylate, and the other uses a piece of tissue from the abdomen called omentum. The goal is to see which method works better to lower the chance of bleeding, pain, or leaks after surgery.
Who can take part?
Adults ages 18-65 who:
* Have a body mass index (BMI) over 35, or over 30 if they also have health problems related to obesity. * Are scheduled to have weight-loss sleeve surgery at Cairo University Hospital.
Participants cannot take part if they:
* Are younger than 18 or older than 65. * Have had weight-loss surgery before.
What will happen in the study?
* Participants will be assigned by chance to one of two groups:
1. Glue group: The staple line will be sealed with medical glue. 2. Omentum group:The staple line will be covered and sewn with a piece of the body's own tissue. * Everyone will have the same type of surgery and be cared for in the same way afterward. * Participants will be monitored closely for one month after surgery to check for problems like bleeding, pain, or leaks. * Follow-up visits will happen within one week after surgery and again at one month.
What are the possible risks? The risks are low and similar to those of regular weight-loss surgery. Some people may feel pain or anxiety after surgery. The study team will watch for any problems and treat them right away.
Why is this study being done? Weight-loss sleeve surgery is common, but sometimes the staple line can leak or bleed. Finding a better way to strengthen it may help people recover more safely and with less pain.
How long will the study last? The study will take about six months to complete, including surgery and follow-up.
Who is running the study? The study is being done by doctors in the General Surgery Department at Cairo University's Faculty of Medicine.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Cairo, Al-Manial Cairo, 11956, Egypt
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A synthetic surgical adhesive applied to the staple line for reinforcement and hemostasis using its proprietary delivery applicator.
pedicled flap of the patient's own greater omentum sutured over the staple line for reinforcement using a PDS 2/0 round needle suture.
Reinforcement of the gastric staple line during laparoscopic sleeve gastrectomy.
Time frame: From surgery up to 30 days postoperatively
This measure compares two methods of staple line reinforcement during laparoscopic sleeve gastrectomy to see which works better at preventing complications within the first 30 days after surgery. The complications of interest are postoperative leakage (staple line leak), bleeding requiring intervention, and abdominal pain. Patients are randomly assigned to have their staple line reinforced either with medical glue (cyanoacrylate) or with the patient's own fatty tissue (omentum).
Time frame: Measured on the day of surgery.
This measure compares the total surgical time (in hours) from skin incision to closure between the two study groups: cyanoacrylate glue reinforcement vs. omentum reinforcement.
Time frame: From surgery until discharge, assessed up to 30 days postoperatively.
This measure compares the number of days patients stay in the hospital after surgery between the two reinforcement groups, from the day of surgery until discharge.
Time frame: Assessed on the day of surgery
This measure compares the direct cost of the reinforcement materials used in each group: cyanoacrylate glue versus omentum
Time frame: From discharge up to 30 days postoperatively.
This measure assesses whether any staple line complications (such as delayed leakage or bleeding) occur after discharge, within the first month post-surgery.
Time frame: Within 30 days after discharge.
This measure compares the proportion of patients in each group who are readmitted to the hospital within 30 days after discharge due to any surgery-related complication.
Time frame: Within 30 days postoperatively.
This measure compares the proportion of patients in each group who require a second surgical intervention (reoperation) within 30 days after the initial surgery due to complications such as bleeding, leakage, or hematoma.
Time frame: Daily from day of surgery up to 7 days postoperatively.
This measure compares patient-reported pain levels (using a visual analog scale, VAS) (VAS, 0-10) during the first 7 days after surgery between the cyanoacrylate and omentum reinforcement groups.
Time frame: From end of surgery up to 48 hours postoperatively.
This measure compares the incidence and severity of postoperative nausea and vomiting (PONV) in the first 48 hours after surgery between the two reinforcement groups.
Time frame: From end of surgery up to 48 hours.
This measure compares the time (in hours) from end of surgery to first tolerated oral fluid intake (sips of water) between the two groups.
Cairo University
Other
Cyanoacrylate Versus Omentum for Enforcement of the Staple Line in Sleeve Operation
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07475169
Body Weight, Hemorrhage
Cairo, Egypt
View Trial DetailsNCT05742165
Behavior, Body Weight
New York, United States
View Trial DetailsNCT05882045
Body Weight, Cardiovascular Diseases
Phoenix, Arizona, United States
View Trial DetailsNCT05929079
Apnea, Body Weight
Anniston, Alabama, United States
View Trial Details